mendmedsBeta
Patient assistance
Free help paying for rare disease medications.
mendmeds tracks 8 rare disease medications, with 16 active assistance programs, each linked to its official source with the date we checked it.
Browse
Every rare disease medication we cover
- Austedo (deutetrabenazine)2 active programsTypically around $8,500 per month without assistance
- Creon (pancrelipase)Medicare options2 active programsTypically around $2,500 per month without assistance
- Hemlibra (emicizumab-kxwh)2 active programsTypically around $21,000 per month without assistance
- Ingrezza (valbenazine)2 active programsTypically around $8,500 per month without assistance
- Soliris (eculizumab)Medicare options2 active programs
- Trikafta (elexacaftor / tezacaftor / ivacaftor)2 active programsTypically around $26,500 per month without assistance
- Ultomiris (ravulizumab-cwvz)2 active programs
- Vyndamax (tafamidis)Medicare options2 active programs